Ireland· IE-PA-EU/1/04/281/001

Erbitux

A cetuximab product containing cetuximab, registered in Ireland by Merck Europe B.V..

ATC L01XC06

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cetuximabAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

HPRA (Ireland)

Active substance: Cetuximab
Manufacturer: Merck Europe B.V.
Country: Ireland (IE)
ATC code: L01XC06
ATC class: Cetuximab
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
EU/1/04/281/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

18 interactions on record for cetuximab.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cetuximab against other medicines How interaction checks work

Cetuximab · interactions on record

18 records

2 severe
16 moderate

Most severe, free to view

Aminolevulinic acidL01XD04severe
ThalidomideL04AX02severe
OmeprazoleA02BC01moderate
PantoprazoleA02BC02moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cetuximab in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cetuximab products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Iceland · Erbitux
Liechtenstein · Erbitux
Norway · Erbitux

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/348aed01-31e6-4e76-9c0f-43d0f812cae5
GET /v1/drugs/348aed01-31e6-4e76-9c0f-43d0f812cae5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01XC",
    "L01XC06"
  ],
  "strength": null,
  "pa_number": "EU/1/04/281/001",
  "substances": [
    "Cetuximab"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "29/06/2004",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about cetuximab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console